Squarepoint’s Kite Pharma, Inc. KITE Stock Holding History

Squarepoint’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-21,317	Closed	-$3.83M	–	2504
2017 Q3	$3.83M	Buy	21,317 +15,775	+285%	+$2.2M	0.07%	342
2017 Q2	$575K	Sell	5,542 -658	-11%	-$53.7K	0.01%	904
2017 Q1	$487K	Buy	+6,200	New	+$383K	0.01%	867
2016 Q4	–	Sell	-4,900	Closed	-$274K	–	2021
2016 Q3	$274K	Buy	+4,900	New	+$273K	0.02%	774

Squarepoint's KITE Position: Q4 2017 in Review

Squarepoint sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 21,317 shares — an estimated $3.83M sold.

Squarepoint first reported a position in KITE in Q3 2016 and held it in 4 quarters. The position peaked at $3.83M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Squarepoint reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Squarepoint sold 21,317 Kite Pharma, Inc. shares in Q4 2017, an estimated $3.83M.
Squarepoint first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 4 quarters.
Squarepoint's Kite Pharma, Inc. position peaked at $3.83M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.